HELP · Cybin Inc.
$11.99
+0.54 (+4.72%)
At close · Aug 14
Market Cap
$743.19M
Shares
61.98M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.99
Open$11.55
Day$11.11–12.03
52W close$3.87–11.99
Avg vol 30d1.9M
Short int3.2M · 5.1% float · 1.7d
Short vol31%
Last earningsNov 13, 2025
DataSep 2024–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Sep 19, 2024; bars on opposite sides are not compared.
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+90%
above
Price vs 50-day avg
+72%
above
RSI (14)
74
overbought
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+65%
trailing
6-month return
+78%
trailing
YTD return
+47%
this year
Relative strength
+64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.09% of float · ▼ -3.2% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
100 holders — near 2-yr high, broad support
Squeeze score
74
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
85%
annualized · 1-yr
Max drawdown
−56%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+90%
Bullish
Price vs 50-day avg
+72%
Bullish
RSI (14)
74
Bearish
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.09% of float · ▼ -3.2% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
100 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $4
Now $12 · 100%
Range high $12
vs 200-day avg +90%
vs 50-day avg +72%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HELP
this stock
Cybin Inc.
|
$743.19M | +46.6% | — | — | 5.1% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Sep 19, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HELP | +3.3% | +65.4% | +78.2% | +53.3% | +46.6% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +2.9% | +60.9% | +64.4% | +49.4% | +32.7% |
Key facts
CIK
1833141
CUSIP
23256X407
13F (30d)
97 filings
96 filers
Visit website
Investor relations